![Bo Öberg](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Bo Öberg
Net worth: 38 055 $ as of 30/05/2024
Career history of Bo Öberg
Former positions of Bo Öberg
Companies | Position | Start | End |
---|---|---|---|
MEDIVIR AB | Director/Board Member | 05/05/2013 | 07/05/2014 |
MEDIVIR AB | Chairman | 31/12/1987 | 31/12/1995 |
Founder | 31/12/1987 | - | |
Astra AB
![]() Astra AB Pharmaceuticals: MajorHealth Technology Astra AB used to manufacture and market cardiovascular preparations, local anesthetics, anti-infective agents and medical-care equipment. The firm's products were Pulmicort, Xylocaine, Marcaine, EMLA and Naropin. It had operations in Scandinavia, Europe, North & South America, Australia, New Zealand, Africa and Asia. The company was headquartered in Södertälje, Sweden. | Corporate Officer/Principal | 31/12/1977 | - |
The International Society for Antiviral Research
![]() The International Society for Antiviral Research Miscellaneous Commercial ServicesCommercial Services The International Society for Antiviral Research operates an institution for the sharing of scientific developments in antiviral medicines. The private company is based in Logan, UT. | Director/Board Member | - | - |
Accuro Immunology AB
![]() Accuro Immunology AB Pharmaceuticals: MajorHealth Technology Accuro Immunology AB develops and manufactures active immunotherapy products. The firm's products help to treat the patients suffering from problems with immune escape/evasion. The company was founded by Peter Gunnar Maurits Wolpert and Elisabeth Wolpert in 1999 and is headquartered in Stockholm, Sweden. | Corporate Officer/Principal | - | - |
ClanoTech AB
![]() ClanoTech AB Pharmaceuticals: MajorHealth Technology ClanoTech AB is a holding company that develops drugs for the treatment of cancer and macular degeneration. Its lead candidate is an inhibitor of the alpha5beta1-integrin receptor which is present in fibroblast and on vascular endothelial cells. Its Alpha5beta1-integrin is strongly up-regulated in fibroblast when switching to the fibrotic state and in scars after glaucoma surgery. Its strategy spans from therapeutic areas with high commercial potential as wet Age Regulated Macular Degeneration to ophthalmology niche indications with orphan drug opportunity such as developing advent in glaucoma surgery techniques. The company was founded by Yihai Cao in 2006 and is headquartered in Solna, Sweden. | Director/Board Member | 05/05/2010 | - |
Bioagri SRL | Corporate Officer/Principal | - | - |
Clean Chemicals Sweden AB
![]() Clean Chemicals Sweden AB Pharmaceuticals: MajorHealth Technology Part of Kiilto Family Oy, Clean Chemicals Sweden AB is a pharmaceutical company based in Borlänge, Sweden. Clean Chemicals Sweden was acquired by Segulah Advisor AB from C.B. Fleet Co., Inc. on May 11, 2011. | Corporate Officer/Principal | - | - |
Beactica Therapeutics AB
![]() Beactica Therapeutics AB Medical DistributorsDistribution Services Beactica Therapeutics AB operates as a drug discovery company, utilizing its proprietary methodologies to evaluate the interactions of molecules in order to generate novel therapeutics. The firm's services include fragment-based lead generation, kinetic and mechanistic characterization of inhibitors, extended rate analysis, competition analysis, and antibody interaction analysis. The company was founded by Per K?llblad and Ulla Helena Danielson in 2006 and is headquartered in Uppsala, Sweden. | Director/Board Member | - | - |
Statistics
International
Sweden | 7 |
Italy | 2 |
United States | 2 |
Operational
Director/Board Member | 4 |
Corporate Officer/Principal | 4 |
Chairman | 1 |
Sectoral
Health Technology | 6 |
Commercial Services | 2 |
Distribution Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
MEDIVIR AB | Health Technology |
Private companies | 7 |
---|---|
Astra AB
![]() Astra AB Pharmaceuticals: MajorHealth Technology Astra AB used to manufacture and market cardiovascular preparations, local anesthetics, anti-infective agents and medical-care equipment. The firm's products were Pulmicort, Xylocaine, Marcaine, EMLA and Naropin. It had operations in Scandinavia, Europe, North & South America, Australia, New Zealand, Africa and Asia. The company was headquartered in Södertälje, Sweden. | Health Technology |
Clean Chemicals Sweden AB
![]() Clean Chemicals Sweden AB Pharmaceuticals: MajorHealth Technology Part of Kiilto Family Oy, Clean Chemicals Sweden AB is a pharmaceutical company based in Borlänge, Sweden. Clean Chemicals Sweden was acquired by Segulah Advisor AB from C.B. Fleet Co., Inc. on May 11, 2011. | Health Technology |
Accuro Immunology AB
![]() Accuro Immunology AB Pharmaceuticals: MajorHealth Technology Accuro Immunology AB develops and manufactures active immunotherapy products. The firm's products help to treat the patients suffering from problems with immune escape/evasion. The company was founded by Peter Gunnar Maurits Wolpert and Elisabeth Wolpert in 1999 and is headquartered in Stockholm, Sweden. | Health Technology |
Bioagri SRL | |
The International Society for Antiviral Research
![]() The International Society for Antiviral Research Miscellaneous Commercial ServicesCommercial Services The International Society for Antiviral Research operates an institution for the sharing of scientific developments in antiviral medicines. The private company is based in Logan, UT. | Commercial Services |
Beactica Therapeutics AB
![]() Beactica Therapeutics AB Medical DistributorsDistribution Services Beactica Therapeutics AB operates as a drug discovery company, utilizing its proprietary methodologies to evaluate the interactions of molecules in order to generate novel therapeutics. The firm's services include fragment-based lead generation, kinetic and mechanistic characterization of inhibitors, extended rate analysis, competition analysis, and antibody interaction analysis. The company was founded by Per K?llblad and Ulla Helena Danielson in 2006 and is headquartered in Uppsala, Sweden. | Distribution Services |
ClanoTech AB
![]() ClanoTech AB Pharmaceuticals: MajorHealth Technology ClanoTech AB is a holding company that develops drugs for the treatment of cancer and macular degeneration. Its lead candidate is an inhibitor of the alpha5beta1-integrin receptor which is present in fibroblast and on vascular endothelial cells. Its Alpha5beta1-integrin is strongly up-regulated in fibroblast when switching to the fibrotic state and in scars after glaucoma surgery. Its strategy spans from therapeutic areas with high commercial potential as wet Age Regulated Macular Degeneration to ophthalmology niche indications with orphan drug opportunity such as developing advent in glaucoma surgery techniques. The company was founded by Yihai Cao in 2006 and is headquartered in Solna, Sweden. | Health Technology |
- Stock Market
- Insiders
- Bo Öberg
- Experience